HILOPROBE

Complete resection of the primary tumor and regional lymph nodes is the most important intervention in the treatment of colorectal cancer, and 70-90% of all colorectal cancer patients may undergo surgical resection. Evaluation of the resected specimen is an essential step in identifying prognostic factors in predicting disease recurrence. The American Joint Committee on Cancer (AJCC) and International Union Against Cancer (UICC) have introduced the tumor-node-metastasis (TNM) staging system, which assesses primary tumor (T), lymph node metastasis (N), and distant metastasis (M) to predict disease recurrence and survival... Colorectal cancer is the third most common cancer type worldwide with >50% of the patients succumbing from the disease.

Also known as: Hiloprobe AB

Primary location: Umeå Sweden